Publications by authors named "Djordje Atanackovic"

99Publications

Role of immunotherapy in Ewing sarcoma.

J Immunother Cancer 2020 Dec;8(2)

Cancer Immunotherapy, Huntsman Cancer Institute, Salt Lake City, Utah, USA

View Article and Find Full Text PDF
December 2020

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide.

Nat Commun 2020 02 7;11(1):798. Epub 2020 Feb 7.

Multiple Myeloma Program & Cancer Immunotherapy, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.

View Article and Find Full Text PDF
February 2020

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma.

Oncoimmunology 2020 13;9(1):1673129. Epub 2019 Oct 13.

Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, USA.

View Article and Find Full Text PDF
October 2019

B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta-analysis.

Eur J Haematol 2020 Apr 20;104(4):318-327. Epub 2020 Jan 20.

Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
April 2020

The role of surface molecule CD229 in Multiple Myeloma.

Clin Immunol 2019 07 13;204:69-73. Epub 2018 Oct 13.

Multiple Myeloma Program & Cancer Immunotherapy, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, United States. Electronic address:

View Article and Find Full Text PDF
July 2019

Biomarkers for checkpoint inhibition in hematologic malignancies.

Semin Cancer Biol 2018 10 18;52(Pt 2):198-206. Epub 2018 Jun 18.

Multiple Myeloma Program & Cancer Immunology, Division of Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, United States.

View Article and Find Full Text PDF
October 2018

Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma.

Curr Cancer Drug Targets 2017 ;17(9):839-845

Department of Stem Cell Transplantatio, University Medical Center Hamburg-Eppendorf, Martinistrabe 52, 20246 Hamburg. Germany.

View Article and Find Full Text PDF
June 2018

Novel anti-myeloma immunotherapies targeting the SLAM family of receptors.

Oncoimmunology 2017;6(5):e1308618. Epub 2017 Mar 28.

Multiple Myeloma Program & Cancer Immunotherapy, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.

View Article and Find Full Text PDF
March 2017

Elotuzumab as a novel anti-myeloma immunotherapy.

Hum Vaccin Immunother 2017 08 12;13(8):1751-1757. Epub 2017 Jun 12.

a Multiple Myeloma Program & Cancer Immunotherapy , Hematology and Hematologic Malignancies, University of Utah / Huntsman Cancer Institute , Salt Lake City , UT , USA.

View Article and Find Full Text PDF
August 2017

Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.

Oncotarget 2017 Jul;8(30):49253-49263

Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article and Find Full Text PDF
July 2017

An Anti-Programmed Death-1 Antibody (αPD-1) Fusion Protein That Self-Assembles into a Multivalent and Functional αPD-1 Nanoparticle.

Mol Pharm 2017 05 19;14(5):1494-1500. Epub 2017 Apr 19.

Department of Pharmaceutics and Pharmaceutical Chemistry, The University of Utah , Salt Lake City, Utah 84112, United States.

View Article and Find Full Text PDF
May 2017

Immunotherapies targeting CD38 in Multiple Myeloma.

Oncoimmunology 2016;5(11):e1217374. Epub 2016 Aug 5.

Multiple Myeloma Program & Cancer Immunology, Hematology and Hematologic Malignancies, University of Utah / Huntsman Cancer Institute , Salt Lake City, UT, USA.

View Article and Find Full Text PDF
August 2016

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:
Kristin A Rand Chi Song Eric Dean Daniel J Serie Karen Curtin Xin Sheng Donglei Hu Carol Ann Huff Leon Bernal-Mizrachi Michael H Tomasson Sikander Ailawadhi Seema Singhal Karen Pawlish Edward S Peters Cathryn H Bock Alex Stram David J Van Den Berg Christopher K Edlund David V Conti Todd Zimmerman Amie E Hwang Scott Huntsman John Graff Ajay Nooka Yinfei Kong Silvana L Pregja Sonja I Berndt William J Blot John Carpten Graham Casey Lisa Chu W Ryan Diver Victoria L Stevens Michael R Lieber Phyllis J Goodman Anselm J M Hennis Ann W Hsing Jayesh Mehta Rick A Kittles Suzanne Kolb Eric A Klein Cristina Leske Adam B Murphy Barbara Nemesure Christine Neslund-Dudas Sara S Strom Ravi Vij Benjamin A Rybicki Janet L Stanford Lisa B Signorello John S Witte Christine B Ambrosone Parveen Bhatti Esther M John Leslie Bernstein Wei Zheng Andrew F Olshan Jennifer J Hu Regina G Ziegler Sarah J Nyante Elisa V Bandera Brenda M Birmann Sue A Ingles Michael F Press Djordje Atanackovic Martha J Glenn Lisa A Cannon-Albright Brandt Jones Guido Tricot Thomas G Martin Shaji K Kumar Jeffrey L Wolf Sandra L Deming Halverson Nathaniel Rothman Angela R Brooks-Wilson S Vincent Rajkumar Laurence N Kolonel Stephen J Chanock Susan L Slager Richard K Severson Nalini Janakiraman Howard R Terebelo Elizabeth E Brown Anneclaire J De Roos Ann F Mohrbacher Graham A Colditz Graham G Giles John J Spinelli Brian C Chiu Nikhil C Munshi Kenneth C Anderson Joan Levy Jeffrey A Zonder Robert Z Orlowski Sagar Lonial Nicola J Camp Celine M Vachon Elad Ziv Daniel O Stram Dennis J Hazelett Christopher A Haiman Wendy Cozen

Cancer Epidemiol Biomarkers Prev 2016 12 1;25(12):1609-1618. Epub 2016 Sep 1.

Keck School of Medicine of USC and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article and Find Full Text PDF
December 2016

Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study.

BMC Palliat Care 2016 Mar 1;15:25. Epub 2016 Mar 1.

Department of Oncology, Hematology, BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hubertus Wald Tumour Center - University Cancer Center Hamburg, Martinistr. 52, 20246, Hamburg, Germany.

View Article and Find Full Text PDF
March 2016

Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.

Br J Haematol 2016 Mar 20;172(5):685-98. Epub 2016 Jan 20.

Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.

View Article and Find Full Text PDF
March 2016

A Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma Consortium.

Cancer Epidemiol Biomarkers Prev 2016 Jan 13;25(1):217-21. Epub 2015 Oct 13.

Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Barcelona, Spain. Department of Medicine, University of Barcelona, Barcelona, Spain. CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.

View Article and Find Full Text PDF
January 2016

Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma.

Br J Haematol 2015 Dec 12;171(5):752-62. Epub 2015 Oct 12.

Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.

View Article and Find Full Text PDF
December 2015

Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Oct;10(10):1458-67

*Thoracic Oncology Unit, Arnaud de Villeneuve Hospital/CHRU Montpellier, Montpellier, France; †Department of Pneumology, University Hospital, KU Leuven, Leuven, Belgium; ‡Medical Oncology, European Institute of Oncology, Milan, Italy; §Division of Hematology and Hematologic Malignancies, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah; ¶Department of Thoracic Oncology, Hospital Grosshansdorf, Grosshansdorf, Germany; ‖Department of Respiratory Medicine, Ziekenhuis Oost Limburg, Genk and LCRP Oncology Cluster, University of Hasselt, Hasselt, Belgium; #Department of Medical Oncologie, ICO R. Gauducheau, St-Herblain, France; **Department of Oncology, University Hospital S. Maria della misericordia, Udine, Italy; ††Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; ‡‡Northwest Lung Centre, University Hospitals of South Manchester, Manchester, United Kingdom; §§Thoracic Oncology-Pneumology Service, André Renard Clinic, Herstal, Belgium; ¶¶Clinic of Thoracic Surgery, Waldburg-Zeil Clinic, Wangen im Allgäu, Germany; and ‖‖GSK Vaccines, Rixensart, Belgium.

View Article and Find Full Text PDF
October 2015

Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.

J Transl Med 2015 Jun 20;13:197. Epub 2015 Jun 20.

Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article and Find Full Text PDF
June 2015

FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.

Cancer Immunol Immunother 2014 Nov 7;63(11):1189-97. Epub 2014 Aug 7.

Universidade Federal de São Paulo [UNIFESP], Rua Diogo de Faria, 824, 5º andar, Hemocentro, São Paulo, CEP 04037-003, Brazil,

View Article and Find Full Text PDF
November 2014

Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation.

Cancer Immunol Immunother 2014 Nov 31;63(11):1151-62. Epub 2014 Jul 31.

Department of Internal Medicine II, Oncology/Hematology/Bone Marrow Transplantation with the Section Pneumology, University Cancer Center Hamburg (Hubertus Wald Tumorzentrum), University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

View Article and Find Full Text PDF
November 2014

5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.

Mediators Inflamm 2014 13;2014:418292. Epub 2014 Mar 13.

Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasße 52, 20246 Hamburg, Germany.

View Article and Find Full Text PDF
December 2014

Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity.

Int J Hematol 2014 Jan 22;99(1):91-4. Epub 2013 Nov 22.

Department of Oncology/Hematology/Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

View Article and Find Full Text PDF
January 2014

Second autologous transplant as salvage therapy in multiple myeloma.

Br J Haematol 2013 Dec 24;163(5):565-72. Epub 2013 Sep 24.

Department of Oncology/Haematology/Bone Marrow Transplantation, Pneumology Section, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
December 2013

Immune-modulating drugs and hypomethylating agents to prevent or treat relapse after allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2014 Feb 22;20(2):168-72. Epub 2013 Sep 22.

Department of Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
February 2014

CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives.

Lung Cancer 2013 Jun 27;80(3):242-8. Epub 2013 Feb 27.

Department of Internal Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
June 2013

Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapy.

Hum Vaccin Immunother 2013 Jun 21;9(6):1205-16. Epub 2013 Feb 21.

Research Department Cell and Gene Therapy; Department of Stem Cell Transplantation (SCT); University Medical Center (UMC) Hamburg-Eppendorf; Hamburg, Germany.

View Article and Find Full Text PDF
June 2013

Role of interleukin 16 in multiple myeloma.

J Natl Cancer Inst 2012 Jul 28;104(13):1005-20. Epub 2012 Jun 28.

Department of Medicine II, Oncology/Hematology/Stem Cell Transplantation, University Cancer Center Hamburg (Hubertus Wald Tumorzentrum), University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, Germany.

View Article and Find Full Text PDF
July 2012

The role of regulatory T cells and TH17 cells in multiple myeloma.

Clin Dev Immunol 2012 27;2012:293479. Epub 2012 Mar 27.

Disciplina de Hematologia e Hemoterapia, Departamento de Oncologia Clínica e Experimental, Campus São Paulo, UNIFESP, Rua Botucatu 740, 3o Andar, 04023-900 São Paulo, SP, Brazil.

View Article and Find Full Text PDF
March 2013

Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.

Clin Dev Immunol 2012 12;2012:134081. Epub 2012 Mar 12.

Department of Internal Medicine II, and Department of Oncology, Hematology, Bone Marrow Transplantation Section of Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

View Article and Find Full Text PDF
March 2013

Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation.

Clin Dev Immunol 2011 15;2011:302145. Epub 2011 Nov 15.

Department of Internal Medicine II, Oncology/Hematology/Bone Marrow Transplantation with the Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
April 2012

Current standards and new trends in the primary treatment of colorectal cancer.

Eur J Cancer 2011 Sep;47 Suppl 3:S312-4

Hubertus Wald Tumor Center, University Cancer Center Hamburg, Germany.

View Article and Find Full Text PDF
September 2011

Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.

Haematologica 2011 Oct 23;96(10):1512-20. Epub 2011 May 23.

Center of Oncology, Department of Medicine II, Oncology/Hematology/Stem Cell Transplantation, University Cancer Center Hamburg (Hubertus Wald Tumorzentrum), Hamburg, Germany.

View Article and Find Full Text PDF
October 2011

Prognostic and diagnostic value of spontaneous tumor-related antibodies.

Clin Dev Immunol 2010 23;2010:721531. Epub 2010 Dec 23.

Department of Oncology, Hematology, Stem Cell Transplantation with the section Pneumology, University Cancer Center Hamburg (Hubertus Wald Tumorzentrum), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

View Article and Find Full Text PDF
April 2011

Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.

Hum Pathol 2010 Nov 24;41(11):1577-85. Epub 2010 Jul 24.

Institute for Pathology, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

View Article and Find Full Text PDF
November 2010

Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

Exp Mol Pathol 2010 Oct 14;89(2):175-81. Epub 2010 Jul 14.

Department of Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
October 2010

The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.

Exp Hematol 2010 Oct 7;38(10):860-7. Epub 2010 Jul 7.

Department of Internal Medicine II (Oncology/Hematology/Stem Cell Transplantation), University Cancer Center Hamburg (Hubertus Wald Tumorzentrum), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
October 2010

Autoantibodies against tumor-related antigens: incidence and biologic significance.

Hum Immunol 2010 Jul 28;71(7):643-51. Epub 2010 Apr 28.

Department of Oncology, Hematology, Stem Cell Transplantation with the Section Pneumology, University Cancer Center Hamburg (Hubertus Wald Tumorzentrum), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
July 2010

An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.

J Immunol Methods 2010 Jun 17;358(1-2):56-65. Epub 2010 Mar 17.

Department of Internal Medicine II (Oncology, Haematology, Stem Cell Transplantation), University Cancer Centre Hamburg (Hubertus Wald Tumorzentrum), Hamburg, Germany.

View Article and Find Full Text PDF
June 2010

Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.

Haematologica 2010 May 16;95(5):785-93. Epub 2009 Dec 16.

Department of Medicine II, Oncology/Hematology, University Medical Center, Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

View Article and Find Full Text PDF
May 2010

Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?

Oncologist 2009 Dec 11;14(12):1242-51. Epub 2009 Dec 11.

Department of Oncology/Hematology/Bone Marrow Transplantation with the Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
December 2009

Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.

Proc Natl Acad Sci U S A 2008 Feb 23;105(5):1650-5. Epub 2008 Jan 23.

Department of Oncology/Hematology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

View Article and Find Full Text PDF
February 2008

Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.

Exp Hematol 2006 Jun;34(6):770-5

Department of Bone Marrow Transplantation, Transplant Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
June 2006

Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cells.

J Neuroimmunol 2006 Jul 18;176(1-2):141-52. Epub 2006 May 18.

Department of Oncology/Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, and Department of Rheumatology and Clinical Immunology, Charité University Hospital, Humboldt-University of Berlin, Germany.

View Article and Find Full Text PDF
July 2006

Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes.

Am J Physiol Regul Integr Comp Physiol 2006 Mar 27;290(3):R585-94. Epub 2005 Oct 27.

Department of Oncology/Hematology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

View Article and Find Full Text PDF
March 2006

Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.

Leuk Res 2005 Sep 16;29(9):1019-27. Epub 2005 Mar 16.

Department of Medicine, Oncology/Hematology, University Hospital Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

View Article and Find Full Text PDF
September 2005

IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation.

Proc Natl Acad Sci U S A 2004 Oct 21;101(40):14467-72. Epub 2004 Sep 21.

Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article and Find Full Text PDF
October 2004

Characterization of effusion-infiltrating T cells: benign versus malignant effusions.

Clin Cancer Res 2004 Apr;10(8):2600-8

Oncology/Hematology, Department of Medicine, University Hospital Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
April 2004

Acute psychological stress induces a prolonged suppression of the production of reactive oxygen species by phagocytes.

J Neuroimmunol 2003 Sep;142(1-2):159-65

Department of Oncology/Hematology, Medical University Clinic Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

View Article and Find Full Text PDF
September 2003

Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC.

J Immunol Methods 2003 Jul;278(1-2):57-66

Ludwig Institute for Cancer Research, Branch at Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 32, New York, NY 10021, USA.

View Article and Find Full Text PDF
July 2003

41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases.

Cancer Immunol Immunother 2002 Dec 18;51(11-12):603-13. Epub 2002 Oct 18.

Department of Oncology and Hematology, University Clinic Eppendorf, Hamburg, Germany.

View Article and Find Full Text PDF
December 2002

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients.

Proc Natl Acad Sci U S A 2002 Sep 19;99(18):11813-8. Epub 2002 Aug 19.

Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article and Find Full Text PDF
September 2002